These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 24246118)

  • 1. [Off-label prescriptions in public psychiatric hospital practice].
    Andréoli L; Gaudoneix M; Beauverie P; de Beaurepaire R
    Therapie; 2013; 68(6):347-59. PubMed ID: 24246118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Off-label prescriptions: how to identify them, frame them, announce them and monitor them in practice?
    Le Jeunne C; Billon N; Dandon A; ; Berdaï D; Adgibi Y; Bergmann JF; Bordet R; Carpentier A; Cohn E; Courcier S; Girault D; Goni S; Jolliet P; Liard F; Prot-Labarthe S; Simon T; Vernotte C; Westerloppe J
    Therapie; 2013; 68(4):225-39. PubMed ID: 23981260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Off-label psychotropic prescribing for young persons in medium security.
    Haw C; Stubbs J
    J Psychopharmacol; 2010 Oct; 24(10):1491-8. PubMed ID: 19423609
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
    Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
    Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-label prescribing during pregnancy in the UK: an analysis of 18,000 prescriptions in Liverpool Women's Hospital.
    Herring C; McManus A; Weeks A
    Int J Pharm Pract; 2010 Aug; 18(4):226-9. PubMed ID: 20636674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Off-label prescribing for allergic diseases in pre-school children.
    Morais-Almeida M; Cabral AJ
    Allergol Immunopathol (Madr); 2014; 42(4):342-7. PubMed ID: 23769737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Assessment off-label prescribing in Dermatology].
    Picard D; Carvalho P; Bonnavia C; Louin L; Josset V; Lauret P; Joly P;
    Ann Dermatol Venereol; 2003 May; 130(5):507-10. PubMed ID: 12843825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In-label and off-label use of respiratory drugs in the Italian paediatric population.
    Baiardi P; Ceci A; Felisi M; Cantarutti L; Girotto S; Sturkenboom M; Baraldi E
    Acta Paediatr; 2010 Apr; 99(4):544-9. PubMed ID: 20105140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescribing for off-label use and unauthorized medicines in three paediatric wards in Finland, the status before and after the European Union Paediatric Regulation.
    Lindell-Osuagwu L; Hakkarainen M; Sepponen K; Vainio K; Naaranlahti T; Kokki H
    J Clin Pharm Ther; 2014 Apr; 39(2):144-53. PubMed ID: 24329556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in anticonvulsant prescribing for Australian children: implications for Quality Use of Medicines.
    Cohen SA; Lawson JA; Graudins LV; Pearson SA; Gazarian M
    J Paediatr Child Health; 2012 Jun; 48(6):490-5. PubMed ID: 22050665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Off-label use of medicines in paediatric inpatients at an Australian teaching hospital.
    Ballard CD; Peterson GM; Thompson AJ; Beggs SA
    J Paediatr Child Health; 2013 Jan; 49(1):38-42. PubMed ID: 23279160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Access to anticancer drugs: many evidence-based treatments are off-label and unfunded by the Pharmaceutical Benefits Scheme.
    Mellor JD; Van Koeverden P; Yip SW; Thakerar A; Kirsa SW; Michael M
    Intern Med J; 2012 Nov; 42(11):1224-9. PubMed ID: 22372936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiplatelet drugs in the elderly: prescriptions often inappropriate and reduced tolerance by associated diseases and drugs.
    Cadiou G; Adam M; Caussin M; Landrin I; Mariette N; Capet C; Mouton-Schleifer D; Remy E; Kadri N; Doucet J
    Fundam Clin Pharmacol; 2012 Apr; 26(2):307-13. PubMed ID: 21241362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug, patient, and physician characteristics associated with off-label prescribing in primary care.
    Eguale T; Buckeridge DL; Winslade NE; Benedetti A; Hanley JA; Tamblyn R
    Arch Intern Med; 2012 May; 172(10):781-8. PubMed ID: 22507695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Off-label prescribing in pediatric outpatients.
    Palmaro A; Bissuel R; Renaud N; Durrieu G; Escourrou B; Oustric S; Montastruc JL; Lapeyre-Mestre M
    Pediatrics; 2015 Jan; 135(1):49-58. PubMed ID: 25511119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Off-label medication use in adult critical care patients.
    Lat I; Micek S; Janzen J; Cohen H; Olsen K; Haas C
    J Crit Care; 2011 Feb; 26(1):89-94. PubMed ID: 20716478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anticonvulsant use after formulary status change for brand-name second-generation anticonvulsants.
    Patel H; Toe DC; Burke S; Rasu RS
    Am J Manag Care; 2010 Aug; 16(8):e197-204. PubMed ID: 20690786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying Off-Label Prescriptions Through Data Mining in Danish Community Pharmacy Servers: An Exploratory Study on Desmopressin, Diclofenac, Fucidin, Mirtazapine and Quetiapine.
    Andrulyte M; Bjerrum OJ
    Basic Clin Pharmacol Toxicol; 2018 Aug; 123(2):155-160. PubMed ID: 29575543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Off-label drug prescriptions among outpatient children and adolescents in Germany--a database analysis].
    Sonntag D; Trebst D; Kiess W; Kapellen T; Bertsche T; Kostev K
    Dtsch Med Wochenschr; 2013 Oct; 138(44):2239-45. PubMed ID: 24150699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label prescribing explained. Why your doctor may recommend meds that aren't FDA-approved for your condition.
    Johns Hopkins Med Lett Health After 50; 2011 Jun; 23(4):7. PubMed ID: 21702115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.